Parse Biosciences Acquires Biomage
Summary
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage. With the acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface. Biomage hosts and supports the largest community instance of Cellenics®, a cloud-based single cell RNA sequencing data analysis platform. “The platform has quickly become a trusted resource for single cell researchers around the world,” said Parse Biosciences co-founder and CTO Charles Roco. Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research.